XTL Biopharmaceuticals Ltd.

XTLB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.38

-$0.02 (-0.83%)

At close: Sep 21, 2026, 4:00 PM ET

$2.29

-$0.09 (-3.63%)

Pre-market: Sep 22, 2026, 8:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020	Q4 2019 Dec 30, 2019	Q3 2019 Sep 29, 2019	Q2 2019 Jun 29, 2019	Q1 2019 Mar 30, 2019
Revenue	451K	162K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	332K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	119K	162K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-2.17M	-1.56M	-947K	-689K	-765K	-790K	-843K	-882K	-880K	-941K	-1.18M	-1.51M	-1.5M	-1.47M	-1.24M	-1.18M	-1.21M	-1.19M	-1.17M	-900K	-842K	-819K	-810K	-794K
Interest Income	34K	158K	154K	154K	156K	57K	58K	54K	45K	18K	8K	8K	5K	5K	5K	25K	32K	67K	87K	62K	81K	46K	1.25M	1.49M
Pretax Income	-1.16M	-1.06M	-718K	-378K	-1.78M	-2.25M	-2.85M	-2.77M	-1.35M	1.5M	1.81M	1.23M	1.01M	-884K	-964K	-1.03M	-1.29M	-2.61M	-3.27M	-5.19M	-1.35M	810K	3.1M	5.99M
Net Income	-1.03M	-1.06M	-718K	-378K	-1.78M	-2.25M	-2.85M	-2.77M	-1.35M	1.5M	1.81M	1.23M	1.01M	-884K	-964K	-1.03M	-1.29M	-2.61M	-3.27M	-5.19M	-1.35M	810K	3.1M	5.99M
Selling & General & Admin	2.05M	1.53M	923K	665K	734K	759K	815K	845K	850K	911K	1.13M	1.46M	1.44M	1.41M	1.19M	1.13M	1.16M	1.16M	1.14M	871K	807K	783K	774K	758K
Research & Development	98K	72K	24K	24K	31K	31K	28K	37K	30K	30K	45K	48K	54K	60K	54K	50K	41K	37K	34K	29K	35K	36K	36K	36K
Other Expenses	147K	116K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.29M	1.72M	947K	689K	765K	790K	843K	882K	880K	941K	1.18M	1.51M	1.5M	1.47M	1.24M	1.18M	1.21M	1.19M	1.17M	900K	842K	819K	810K	794K
Interest Expense	86K	122K	57K	76K	85K	85K	57K	36K	20K	24K	30K	33K	31K	27K	21K	16K	9K	9K	9K	n/a	5K	2.44M	2.44M	2.46M
Selling & Marketing Expenses	178K	284K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.62M	1.72M	947K	689K	765K	790K	843K	882K	880K	941K	1.18M	1.51M	1.5M	1.47M	1.24M	1.18M	1.21M	1.19M	1.17M	900K	842K	819K	810K	794K
Income Tax Expense	-130K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9K	9K	9K	9K	n/a	-7K	-7K	-7K	-24K	-38K	-38K	-38K	-21K
Shares Outstanding (Basic)	420.65K	340.59K	340.59K	340.59K	340.57K	340.57K	340.57K	340.57K	340.57K	340.57K	340.57K	340.57K	340.39K	330.1K	329.87K	329.49K	321.38K	321.38K	321.38K	321.38K	321.38K	321.38K	321.38K	321.38K
Shares Outstanding (Diluted)	440.1K	340.59K	340.59K	340.59K	340.57K	340.57K	340.57K	340.57K	340.57K	340.57K	340.57K	340.57K	360.43K	336.15K	329.87K	329.49K	321.38K	321.38K	321.38K	321.38K	321.38K	321.38K	321.38K	321.38K
EPS (Basic)	-2.88	-3.04	-2.08	-1.12	-5.28	-6.72	-8.48	-8.16	-4	4.64	5.44	3.68	3.84	-5.76	-5.92	-6.24	-7.68	-8	-10	-16	-3.52	4.80	12	21
EPS (Diluted)	-2.88	-3.04	-2.08	-1.12	-5.28	-6.72	-8.48	-8.16	-4	4.16	5.12	3.36	3.52	-5.60	-5.92	-6.24	-7.68	-8	-10	-16	-3.52	4.80	12	21
EBITDA	-791.25K	-646K	-632K	-95K	-819K	-759.75K	-886.75K	-929.75K	-939.5K	-1M	-941.25K	-1.27M	-1.26M	-1.23M	-1.02M	-937.5K	-705.75K	-449K	-449K	-1.61M	-1.61M	-4.37M	-3.34M	-1.67M
EBIT	-1.15M	-950K	-677K	-318K	-1.7M	-1.64M	-2.35M	-2.29M	-880K	-941K	354K	-516K	-1.26M	-1.23M	-1.85M	-1.63M	-1.65M	-1.64M	-1.62M	-4.98M	-4.92M	-7.44M	-6.21M	-1.87M
Depreciation & Amortization	528.75K	479.25K	175.5K	175.75K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	217.75K	218K	474.75K	718.5K	700.5K	900K	842K	598K	1.62M	1.66M